-
Allergy & Clinical Immunology -
Cardiovascular Medicine -
Gastroenterology & Hepatology -
General Medicine -
Genetic Medicine -
Geriatric & Palliative Medicine -
Hematology & Oncology -
Hospital Medicine -
Infectious Diseases -
Metabolism, Endocrinology & Diabetes -
Nephrology -
Pulmonary & Critical Care Medicine -
Rheumatology
Infectious Diseases Programs
The U-M Medical School Department of Internal Medicine Division of Infectious Diseases has become more internally specialized over the past 50 years in response to growing needs and has evolved to include the below clinical and research programs.
Learn more about the programs by jumping to the sections below:
Antimicrobial Stewardship Program
The Antimicrobial Stewardship Program (ASP) at Michigan Medicine is a collaborative effort between the Division of Infectious Diseases, Division of Pediatric Infectious Diseases, Department of Pharmacy Services, Infection Prevention, and Clinical Microbiology. The ASP was established to promote appropriate and judicious antimicrobial therapy, optimize patient outcomes, minimize patient harm, and mitigate the emergence of antibiotic resistance. Our antimicrobial stewardship efforts optimize patient care across diverse settings including hospitals, clinics, emergency department, and at transitions of care. The ASP is directed by Tejal N. Gandhi, MD and Jerod Nagel, PharmD in conjunction with Samuel Aitken, PharmD; Karen Davidge, PharmD; Nicholas Dillman, PharmD; Gregory Eschenauer, PharmD; Marten Hawkins, MD; Elizabeth Lloyd, MD; Lindsay Petty, MD; Jason Pogue, PharmD; Daniel Riggsbee, PharmD; Samantha Sallerson, PharmD; Louis Saravolatz, MD; Jordan Smith, PharmD; Alison Tribble, MD; Xuping Yan, PharmD; and Shiwei Zhou, MD.
In addition to our hospital ASP, we have an Ambulatory ASP and a Complex Outpatient Antimicrobial Therapy (COpAT) Program. The Ambulatory ASP focuses on optimizing antimicrobial selection and reducing excess duration for common infections and is led by Lindsay Petty, MD; Nicholas Dillman, PharmD; and Elizabeth Lloyd,MD. The COpAT program is led by Shiwei Zhou, MD; Louis Saravolatz, MD; Jordan Smith, PharmD; and Xuping Yan, PharmD. The goal of the COpAT program is to facilitate the safer administration of complex oral and intravenous antimicrobial regimens in the outpatient setting for Michigan Medicine patients with complex infections.
Since 2017, our program has been recognized as an Antimicrobial Stewardship Center of Excellence by the Infectious Diseases Society of America. This designation recognizes institutions that have policies and processes in place to consistently deliver high-quality stewardship services, implement novel stewardship principles, and demonstrate a high-level of commitment to improving antimicrobial use and reducing resistance.
HIV/AIDS Treatment Program
In 1995, in response to the AIDS epidemic, we established the HIV/AIDS Treatment Program (HATP). Under the leadership of James (Jamie) Riddell IV, MD and Jennifer Hawkins, the program provides comprehensive care for the whole person, utilizing a multi-focused team approach that addresses not only the patient's medical needs, but also psychosocial needs.
The HATP has a tripartite mission:
- Provide excellent comprehensive and longitudinal primary and specialty care for all people living with HIV/AIDS
- Provide education and training along standards of quality related to HIV/AIDS care to other health providers, both within and outside of Michigan Medicine
- Maintain an active clinical research program, offering expanded access to new and promising treatments for all people living with HIV/AIDS
In the past, we have focused our research efforts on the development of many of the antiretroviral medications that are presently in common use today. Currently, we are working on finding more long-term curative therapies by studying the HIV reservoir. In particular, we are interested in bone marrow stem cells as a reservoir site, as well as immune cells associated with the GI tract. We also are investigating strategies to improve HIV adherence in Mozambique. All of these studies are collaborative in nature and involve large teams leveraging their individual areas of expertise to solve complex problems.
Our HIV/AIDS Treatment Program (HATP) has received funding from the Health Resources and Services Administration’s (HRSA) Ryan White HIV/AIDS Program since 1995. The Ryan White HIV/AIDS Program funds grants to states, cities/counties, and local community-based organizations to provide care and treatment services to people living with HIV to improve health outcomes and reduce HIV transmission among hard-to-reach populations.
Our program currently receives Ryan White HIV/AIDS Program Part C funding from HRSA and Part B funding through the Michigan Department of Health and Human Services (MDHHS). The HATP is funded to provide primary medical care services, mental health services, psychiatric services, nutritional services, medical case management, and emergency financial assistance.
Making a gift to our program will support our research and understanding of HIV and AIDS in order to advance patient care. To make a gift, please visit the HIV/Aids Education & Research online giving page.
- James Riddell IV, MD (Medical Director)
- Owen Albin, MD
- Lizbeth Cahuyame-Zuniga, MD
- Sandro Cinti, MD
- Tejal Gandhi, MD
- Sarah Imam, MD
- Daniel Kaul, MD
- Ian Kidder, MD
- Sara Kurz, MD
- Lindsay Petty, MD
- Zoe Raglow, MD
- Adam Ressler, MD
- Danica Rockney, MD
- Louis Saravolatz, MD
- Anastasia Wasylyshyn, MD
- Shiwei Zhou, MD
Infection Prevention & Hospital Epidemiology (IPE)
The Department of Infection Prevention and Epidemiology (IPE) is led by Hospital Epidemiologist, Laraine Washer, MD, and Associate Hospital Epidemiologists, Emily Stoneman, MD; Anastasia Wasylyshyn, MD; Adam Ressler, MD, MPH; and Kavita Warrier, MD, MPH.
The goal of IPE is to ensure that the University of Michigan Health clinical community has current information to protect patients and personnel from adverse events caused by infectious agents. The department provides expertise in infection prevention and control, through education, research, product selection, consultation, quality improvement activities and policy formation.
IPE focuses on using evidence-based practices to prevent healthcare associated infections including device associated infections, surgical site infections, and infections due to antibiotic resistant organisms. The department is also responsible for isolation policies and practices, emerging infection preparedness, and educating healthcare personnel on their roles in preventing infections. The department regularly reports data on healthcare associated infections to the Center for Disease Control’s National Healthcare Surveillance Network.
Multidisciplinary Endocarditis Team
Endocarditis is an infection of the heart valves which can cause severe illness involving many organ systems requiring a team approach to optimally care for patients with this infection. Our Multidisciplinary Endocarditis Team (MET), led by Sarah Kurz, MD, includes specialists from infectious diseases, cardiology, neurology, and cardiac surgery. In addition, we collaborate with internists, interventional radiologists, nuclear medicine physicians, addiction medicine providers, and other health care providers on an as needed basis. Since the multidisciplinary approach began, significant improvements to patient outcomes have been observed.
Transplant Infectious Disease Service
Organ and stem cell transplants can be life-saving treatments for people with organ failure or certain cancers. These procedures offer a second chance at life. However, after a transplant, patients must take medications that weaken the immune system to prevent rejection. This makes it harder for the body to fight infections.
Our Transplant Infectious Disease service specializes in caring for patients with weakened immune systems. For over 20 years, our team has focused on preventing, diagnosing, and treating infections in people who have received organ transplants or stem cell (bone marrow) transplants.
At Michigan Medicine, we care for a large number of transplant patients each year. Our transplant programs perform hundreds of organ and stem cell transplants annually. We work closely with transplant doctors, cancer specialists, and other care teams to make sure patients receive coordinated, comprehensive care.
In addition to patient care, our team is involved in research to find better ways to prevent and treat infections in people with weakened immune systems. Our experts also help develop national and international guidelines to improve care for transplant patients everywhere.
- Daniel Kaul, MD (Medical Director)
- Lizbeth Cahuayme-Zuniga, MD
- Sabrina Imam, MD
- Marisa Miceli, MD
- Lindsay Petty, MD
- Zoe Raglow, MD
- Marc Trubin, MD
